ChemoMetec company profile
Company profile
ChemoMetec has 174 employees and is headquartered in Allerød, Denmark.
Analytical equipment for cell counting and analysis forms the core of the business of ChemoMetec, which sells its instruments in the United States, Canada, Europe and other international markets. Its NucleoCounter range, including the NC-3000 image cytometer, the NC-250 automated cell analyzer and the NC-203 cell counter for complex samples, serves customers working on advanced therapies, oncology and stem cell studies, and the development and production of medicines. The line also includes the SP-100 automated sperm cell counter for animal reproduction and the XcytoMatic 40 cell density and viability analyzer. Beyond instruments, the company supplies cassettes, reagents, slides, software, accessories and labware, along with service, validation plans and training, and it also serves the production and quality control of animal semen, milk and beer.
In the fiscal year ended June 2026, revenue was DKK 511.1 million, up 3.1% on the previous year, and net income reached DKK 201.8 million. The company has 174 employees. Its headquarters are in Allerød, Denmark, and it was incorporated in 1997.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Denmark
- Headquarters
- Gydevang 43, 3450, Allerød
- Employees
- 174
- Chief executive
- Martin Behrens
- Founded
- 1997
- Fiscal year
- July - June
- Listing
- CHEMM · Nasdaq Copenhagen
- Currency
- DKK
- ISIN
- DK0060055861
- Website
- chemometec.com
ChemoMetec and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| ChemoMetecCHEMM | Denmark | $1.75B | 174 | 49.1% | 59.9 |
| El.En.ELN | Italy | $1.44B | 1,459 | 14.7% | 20.7 |
| ElektaEKTA.B | Sweden | $2.27B | 3,996 | 9.2% | — |
| Medacta GroupMOVE | Switzerland | $2.41B | 2,273 | 15.2% | 27.7 |
| GN Store NordGN | Denmark | $2.46B | 7,856 | 10.9% | 90.2 |
| AmbuAMBU.B | Denmark | $3.4B | 4,664 | 13.2% | 36.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
